IP Library Granted Patent US 7,312,087
Granted Patent B2
US 7,312,087 · App. 09/760,384 · Granted Dec 25, 2007

Devices and methods for biochip multiplexing

Assignee: Clinical Micro Sensors, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,312,087
App. No.
09/760,384
Granted
Dec 25, 2007
Kind
B2
Abstract

The invention is directed to devices and methods that allow for simultaneous multiple biochip analysis. The method of analyzing the plurality of biochips includes inserting a first biochp into a first station of an analysis device, inserting a second biochip into a second station of the analysis device, wherein each of the first and second biochips include a substrate, the substrates including an array of detection electrodes, each electrode including a different capture binding ligand, a different target analyte, and a label, and a plurality of electrical contracts, detecting current as an indication of the presence of the labels on the first biochip, and detecting current as an indication of the presence of the labels on the first second biochip. The devices and method may be used with multiple cartridges comprising biochips comprising arrays, such as nucleic acid arrays, and allow for high throughput analysis of samples.

Claims (27)

1. A method of analyzing a plurality of biochips comprising

a) inserting a first biochip into a first station of an analysis device;

b) inserting a second biochip into a second station of the analysis device, wherein each of said first and second biochips comprise a substrate comprising:

an array of detection electrodes, each comprising:

i) a different capture binding ligand;

ii) a different target analyte; and

iii) a label; and;

a plurality of electrical contacts;

c) detecting current as an indication of the presence of said labels on said first biochip; and

d) detecting current as an indication of the presence of said labels on said second biochip.

2. A method according to claim 1 , wherein said capture binding ligands are nucleic acid capture probes, said target analytes are target nucleic acid sequences, and said nucleic acid capture probes hybridize to said target nucleic acid sequences to form hybridization complexes.

3. A method according to claim 2 , wherein said hybridization complexes comprise said capture probes hybridized to said target sequences, respectively.

4. A method according to claim 2 , wherein said labels are covalently attached to said target sequences.

5. A method according to claim 1 or 2 , wherein said labels are hybridization indicators.

6. A method according to claim 5 , wherein said hybridization indicators are intercalators.

7. A method according to claim 2 , wherein said target sequences each comprise a first domain and a second domain, said hybridization complexes each comprise:

a) said capture probes hybridized to said first domains of said target sequences; and

b) label probes hybridized to said second domains of said target sequences.

8. A method according to claim 7 wherein said label probes each comprise three or more covalently attached labels.

9. A method according to claim 1 , 2 or 8 wherein said labels are electron transfer moieties (ETMs).

10. A method according to claim 9 wherein said ETMs are transition metal complexes.

11. A method according to claim 10 wherein said transition metal complexes are metallocenes.

12. A method according to claim 1 , further comprising:

a) receiving detection information from said first biochip at a processor; and

b) receiving detection information from said second biochip at said processor.

13. A method according to claim 12 , further comprising analyzing said received detection information.

14. A method according to claim 13 , wherein said analyzing step comprises analyzing higher harmonic frequencies.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2021
From: GENMARK DIAGNOSTICS, INC.
To: ROCHE MOLECULAR SYSTEMS, INC.
Reel/Frame 058189/0563 →
RELEASE OF SECURITY INTEREST Recorded Oct 9, 2012
From: SQUARE 1 BANK
To: OSMETECH TECHNOLOGY, INC.
Reel/Frame 029097/0148 →
SECURITY INTEREST Recorded Apr 1, 2010
From: OSMETECH TECHNOLOGY INC.
To: SQUARE 1 BANK
Reel/Frame 024312/0662 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2008
From: CLINICAL MICRO SENSORS INC. (DBA OSMETECH MOLECULAR DIAGNOSTICS)
To: OSMETECH TECHNOLOGY INC.
Reel/Frame 021924/0376 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2002
From: DUONG, HAU H.; BLACKBURN, GARY; KAYYEM, JON F.; O'CONNOR, STEPHEN D.; OLSEN, GARY T.; PIETRI, ROBERT; TERBRUEGGEN, ROBERT H.
To: CLINICAL MICRO SENSORS, INC.
Reel/Frame 012507/0900 →
Continuity (1)
Related Publication 20070189921A1 · Aug 16, 2007